• Paxlovid in COVID-19 Vaccinated patients

  • Jun 16 2024
  • Length: 26 mins
  • Podcast

Paxlovid in COVID-19 Vaccinated patients By cover art

Paxlovid in COVID-19 Vaccinated patients

Listen for free

View show details

  • Summary

  • Join us as we explore new trial data examining Paxlovid's effectiveness in high-risk, vaccinated patients.

    The GameChanger
    Significantly high-risk patients are still at risk from active Covid-19 infection. A new trial looks at Paxlovid use in high-risk, vaccinacated patients.

    Host
    Jen Moulton, BSPharm
    President, CEimpact

    Guest
    Geoff Wall, PharmD, BCPS, FCCP, BCGP
    Professor of Pharmacy Practice, Drake University
    Internal Medicine/Critical Care, UnityPoint Health

    Reference
    New England Journal of Medicine Article

    Pharmacists, REDEEM YOUR CPE HERE!
    CPE is available to Health Mart franchise members only
    To learn more about Health Mart, click here: https://join.healthmart.com/

    CPE Information
    Learning Objectives
    Upon successful completion of this knowledge-based activity, participants should be able to:
    1. Discuss EPIC SR study findings.
    2. Describe benefits of Paxlovid for specific patient groups based on trial data.

    0.05 CEU/0.5 Hr
    UAN: 0107-0000-24-172-H01-P
    Initial release date: 05/13/2024
    Expiration date: 05/13/2025
    Additional CPE details can be found here.
    Show more Show less
activate_primeday_promo_in_buybox_DT
Education Physical Illness & Disease Hygiene & Healthy Living Science
Show more Show less

What listeners say about Paxlovid in COVID-19 Vaccinated patients

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available